Drug profile · INN
deferiprone
FERRIPROX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
deferiprone (FERRIPROX) is an FDA-listed pharmaceutical active ingredient. Associated with Chiesi Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN deferiprone
Brand FERRIPROX
Route ORAL
Formulation SOLUTION
ATC code V03AC02
Originator Chiesi Australia Pty Ltd
Frequently asked questions
What is deferiprone?
deferiprone (FERRIPROX) is an FDA-listed pharmaceutical active ingredient. Associated with Chiesi Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for deferiprone?
FERRIPROX is a marketed brand name for deferiprone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of deferiprone?
deferiprone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.